SB Investment Advisers (UK) Ltd's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Aug 28, 2026
- Accession no.
- 0001493152-26-040513
- Filed
- Aug 28, 2026, 9:01 AM ET
- Trade date
- Aug 25, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $116.4M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| SB Investment Advisers (UK) LtdCIK 0001731509 | 10% Owner |
| Softbank Vision Fund (Aiv M2) L.P.CIK 0001805808 | 10% Owner |
| SVF Pauling (Cayman) LtdCIK 0001817592 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | SSaleDisposed | −6,000,000 | $19.40 | −$116,400,000 | 21,904,963 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.